Stock screener
Filter the covered US universe by sector, size, profitability, dividends and performance. Every screen has its own shareable link — the address bar reflects your filters.
Showing 1–30 of 577 companies · sorted by market cap (low to high)
254 covered companies have no sector on record (3IN.L, AAF.L, AAL.L, ABDN.L, ABF.L, ADM.L, AEP.L, AJB.L, ALFA.L, AML.L, ANTO.L, AO.L), so they were not tested by this filter — a gap in our sector data, not evidence they do not belong here.
| Ticker | Company | Sector | Price | Market cap | P/E | Rev growth | Net margin | Div yield | 1y return |
|---|---|---|---|---|---|---|---|---|---|
| CNTX | CONTEXT THERAPEUTICS INC | Health Care | $0.3617 | $33M | n/a | n/a | n/a | n/a | -56.3% |
| KPTI | KARYOPHARM THERAPEUTICS INC | Health Care | $1.79 | $41M | n/a | +6.3% | -134.2% | n/a | -73.4% |
| ELTX | ELICIO THERAPEUTICS INC | Health Care | $2.41 | $46M | n/a | -91.9% | -1225.9% | n/a | -77.8% |
| TENX | TENAX THERAPEUTICS INC | Health Care | $1.94 | $51M | n/a | -82.9% | n/a | n/a | -67.7% |
| HRTX | HERON THERAPEUTICS INC | Health Care | $0.3439 | $65M | n/a | +1.0% | n/a | n/a | -73.9% |
| OTLK | Outlook Therapeutics, Inc. | Health Care | $0.6665 | $81M | n/a | -22.9% | -4416.2% | n/a | -24.9% |
| CVRX | CVRX INC | Health Care | $3.05 | $81M | n/a | +11.7% | -94.1% | n/a | -60.4% |
| ALDX | Aldeyra Therapeutics, Inc. | Health Care | $1.48 | $89M | n/a | n/a | n/a | n/a | -73.2% |
| ACH | ACCENDRA HEALTH INC | Health Care | $1.21 | $93M | n/a | -74.7% | -39.8% | n/a | -77.6% |
| HYPR | HYPERFINE INC CLASS A | Health Care | $0.8133 | $95M | n/a | +30.7% | -262.3% | n/a | -27.4% |
| MBOT | Microbot Medical Inc. | Health Care | $1.44 | $97M | n/a | -50.0% | n/a | n/a | -57.3% |
| GNLX | Genelux Corp | Health Care | $2.44 | $110M | n/a | -91.0% | -401812.5% | n/a | -29.9% |
| GUTS | Fractyl Health, Inc. | Health Care | $0.6966 | $111M | n/a | n/a | n/a | n/a | -22.6% |
| CUE | Cue Biopharma, Inc. | Health Care | $27.44 | $111M | n/a | +309.6% | -96.9% | n/a | +16.5% |
| NAUT | NAUTILUS BIOTECHNOLGY INC | Health Care | $0.9049 | $115M | n/a | n/a | n/a | n/a | +38.8% |
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | Health Care | $1.84 | $116M | n/a | n/a | -86687.5% | n/a | +3.4% |
| JYNT | The Joint Corp | Health Care | $8.32 | $118M | 32.0 | -38.6% | -8.3% | n/a | -22.0% |
| AARD | Aardvark Therapeutics, Inc. | Health Care | $5.38 | $118M | n/a | n/a | n/a | n/a | -36.6% |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | Health Care | $2.12 | $122M | n/a | n/a | n/a | n/a | -26.1% |
| VTVT | vTv Therapeutics Inc. | Health Care | $33.35 | $125M | n/a | n/a | n/a | n/a | +79.9% |
| HCAT | Health Catalyst, Inc. | Health Care | $1.69 | $127M | n/a | -7.5% | -57.2% | n/a | -48.8% |
| QTRX | QUANTERIX CORP | Health Care | $2.69 | $127M | n/a | +6.8% | -77.1% | n/a | -37.7% |
| APYX | Apyx Medical Corp | Health Care | $3.05 | $128M | n/a | +18.2% | -21.2% | n/a | +48.8% |
| MXCT | MaxCyte, Inc. | Health Care | $1.28 | $132M | n/a | -14.3% | -135.1% | n/a | -5.9% |
| IMDX | Insight Molecular Diagnostics Inc. | Health Care | $4.13 | $135M | n/a | -49.3% | -1238.5% | n/a | +67.2% |
| STXS | STEREOTAXIS INC | Health Care | $1.39 | $139M | n/a | +13.4% | -66.8% | n/a | -49.6% |
| EQ | Equillium, Inc. | Health Care | $2.21 | $140M | n/a | n/a | -19.6% | n/a | +26.3% |
| UNCY | UNICYCIVE THERAPEUTICS INC | Health Care | $5.16 | $144M | n/a | n/a | -4525.0% | n/a | +19.4% |
| INGN | INOGEN INC | Health Care | $5.42 | $144M | n/a | +3.4% | -6.5% | n/a | -33.3% |
| OKUR | ONKURE THERAPEUTICS INC CLASS A | Health Care | $3.58 | $145M | n/a | n/a | n/a | n/a | +33.1% |
Every view here has its own address — copy the link from your browser to share exactly what you are looking at. Click a column header to sort.
Data: SEC EDGAR (filings) + market data (prices, fundamentals). Prices on this page are from the 2026-09-04 close or later — each figure is labelled with its own as-of date.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date. Past performance does not indicate future results.